| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029063451 |
| P356 | DOI | 10.1186/SCRT94 |
| P932 | PMC publication ID | 3340547 |
| P698 | PubMed publication ID | 22277374 |
| P5875 | ResearchGate publication ID | 221777494 |
| P50 | author | Roberto Furlan | Q30506343 |
| Antonio Uccelli | Q57007173 | ||
| P2093 | author name string | Tiziana Vigo | |
| Sara Morando | |||
| Giovanni Novi | |||
| Marianna Esposito | |||
| Maria Cristina Principato | |||
| Simona Casazza | |||
| P2860 | cites work | Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice | Q24534272 |
| Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views | Q28251015 | ||
| A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage | Q28287540 | ||
| Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis | Q28295588 | ||
| Mesenchymal stem cells in health and disease | Q29614296 | ||
| Mesenchymal and haematopoietic stem cells form a unique bone marrow niche | Q29616602 | ||
| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
| Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 | Q29620590 | ||
| Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner | Q33438830 | ||
| Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection | Q33916838 | ||
| Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). | Q36041377 | ||
| Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease | Q36141625 | ||
| Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. | Q36457107 | ||
| Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses | Q36936307 | ||
| Remyelination of the spinal cord following intravenous delivery of bone marrow cells | Q37020042 | ||
| Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. | Q37253314 | ||
| Mesenchymal stem cell homing: the devil is in the details | Q37407769 | ||
| The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group | Q37677911 | ||
| Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? | Q37811173 | ||
| Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases | Q37891375 | ||
| Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. | Q39698715 | ||
| Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo | Q39823115 | ||
| Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis | Q39930711 | ||
| Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells | Q40317890 | ||
| Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 | ||
| Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration | Q43195511 | ||
| Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis | Q43831215 | ||
| Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery | Q44115092 | ||
| Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice | Q46499204 | ||
| Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis | Q48227850 | ||
| Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival | Q48371412 | ||
| Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | Q48497239 | ||
| Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. | Q50632074 | ||
| Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. | Q50639315 | ||
| Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
| Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis | Q57041496 | ||
| Experimental autoimmune encephalomyelitis in the mouse | Q82837777 | ||
| Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2 | Q83483089 | ||
| P433 | issue | 1 | |
| P921 | main subject | cell | Q7868 |
| experimental autoimmune encephalomyelitis | Q494066 | ||
| mesenchymal stem cell | Q1922379 | ||
| stem cell transplantation | Q65592366 | ||
| biomedical investigative technique | Q66648976 | ||
| P304 | page(s) | 3 | |
| P577 | publication date | 2012-01-26 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms | |
| P478 | volume | 3 |
| Q38693428 | Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model |
| Q36428498 | Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis |
| Q54565698 | Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts. |
| Q48029148 | CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells. |
| Q47885870 | Cell-based therapeutic strategies for multiple sclerosis |
| Q38265206 | Cell-based therapy approaches: the hope for incurable diseases |
| Q57834200 | Control of Mesenchymal Stem-Cell Fate by Engineering the Nanoenvironment |
| Q90315907 | Establishing an Organotypic System for Investigating Multimodal Neural Repair Effects of Human Mesenchymal Stromal Stem Cells |
| Q33776557 | How stem cells speak with host immune cells in inflammatory brain diseases |
| Q37350687 | Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism |
| Q42359964 | Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism |
| Q42102145 | Immune remodelling of stromal cell grafts in the central nervous system: therapeutic inflammation or (harmless) side-effect? |
| Q27026892 | Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications |
| Q42708747 | Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF-β Secretion. |
| Q64233410 | Mesenchymal Stem Cells from Chronic Pancreatitis Patients Show Comparable Potency Compared to Cells from Healthy Donors |
| Q35213818 | Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE) |
| Q26770191 | Mesenchymal stem cells and immunomodulation: current status and future prospects |
| Q38057682 | Mesenchymal stem cells as treatment for MS - progress to date. |
| Q26801575 | Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders |
| Q41959289 | Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications |
| Q40198530 | Molecular Mechanisms Mediating Retinal Reactive Gliosis Following Bone Marrow Mesenchymal Stem Cell Transplantation. |
| Q27026108 | Molecular characterization of heterogeneous mesenchymal stem cells with single-cell transcriptomes |
| Q39216274 | Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury |
| Q99567540 | Overexpression of alpha-1 antitrypsin in mesenchymal stromal cells improves their intrinsic biological properties and therapeutic effects in nonobese diabetic mice |
| Q47780740 | PGE2 contributes to in vitro MSC-mediated inhibition of non-specific and antigen-specific T cell proliferation in MS patients |
| Q91708011 | Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells |
| Q34391064 | Stem cell transplantation in neurological diseases: improving effectiveness in animal models |
| Q27006474 | Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies |
| Q55155674 | Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight. |
| Q64260095 | The Potential of Stem Cell Therapy to Repair White Matter Injury in Preterm Infants: Lessons Learned From Experimental Models |
| Q35861092 | The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model |
| Q38098448 | Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system |
| Q58805029 | effects of allogeneic mesenchymal stem cells in a rat model of acute ischemic kidney injury |
Search more.